What is the role of low-molecular-weight heparin (LMWH) in the treatment of disseminated intravascular coagulation (DIC)?

Updated: Dec 06, 2020
  • Author: Marcel M Levi, MD; Chief Editor: Srikanth Nagalla, MBBS, MS, FACP  more...
  • Print

The use of low-molecular-weight heparin (LMWH) has been studied in DIC. Enoxaparin has been used for treatment and prophylaxis of chronic DIC in specific clinical situations. In a multicenter, cooperative, double-blinded trial from Japan that compared dalteparin with unfractionated heparin, the former was associated with a decreased bleeding tendency and reduced organ failure. [80] One randomized clinical trial showed LMWH to be superior for reducing 28-day mortality in patients with severe sepsis. [83]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!